top of page
Recent Posts
We are pleased to announce that sotatercept, a new drug for patients diagnosed with pulmonary arterial hypertension (PAH), is now listed on Health Canada's website with the mention “Being reviewed und
The US Food and Drug Administration (FDA) has granted approval for the medication sotatercept, a significant milestone in the treatment of pulmonary arterial hypertension (PAH). Sotatercept, which wil
bottom of page